ClinicalTrials.govpublic full text
Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets
type 2 diabetes mellitus (t2dm)
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 18548 · SHA-256 17c3746fc8cd5ac2
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.